Browsing Category
Pharma Industry News
4720 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Aditxt eyes Pearsanta IPO and oncology pivot as ADTX (NASDAQ) tests retail patience
Aditxt regained Nasdaq compliance, then filed to issue 148 million shares. ADTX retail investors are watching Pearsanta's IPO and a bitXbio crypto pivot.
Can LTI-03 break through in a crowded idiopathic pulmonary fibrosis market
Rein Therapeutics advances LTI-03 in Phase 2 IPF trials. Find out what this means for competition, execution risk, and future differentiation.
What the LEGION-100 trial could mean for the future of combination immunotherapy strategies
Can the LEGION-100 trial redefine immunotherapy strategies? Explore what Syncromune Inc.’s approach means for oncology and future cancer treatments.
How FMISO PET imaging could reduce toxicity in oropharyngeal carcinoma
Can FMISO PET imaging reduce radiation toxicity in cancer care? Discover how Juniper Biosciences is reshaping treatment strategies.
Can KST-6051 unlock broader KRAS cancer treatment beyond G12C inhibitors
KST-6051 enters Phase 1 with AbbVie Inc. backing. Discover how pan-KRAS inhibitors could expand treatment across KRAS-driven cancers.
How tetrahedral antibody design may improve efficacy and safety in immune-mediated diseases
Biomolecular Holdings LLC patents tetrahedral antibodies. Discover how this design could reshape efficacy and safety in immune-mediated diseases.
Why Arcutis Biotherapeutics, Inc. is targeting infant eczema with ZORYVE cream
Can ZORYVE cream unlock infant eczema markets? Discover how Arcutis Biotherapeutics, Inc. is reshaping dermatology strategy today.
Is ATEV the first scalable alternative to autologous fistulas in hemodialysis access
Can Humacyte, Inc. turn ATEV into a viable dialysis access alternative? Dive into Phase 3 signals, risks, and market impact shaping its future.
BeOne Medicines wins FDA Priority Review for TEVIMBRA in HER2-positive GEA as ONC stock faces trial-to-approval test
BeOne has survival data and FDA momentum. The bigger question is whether TEVIMBRA can change first-line HER2-positive GEA care.
Why Heart3D fusion imaging could become critical for scaling cardiac cell therapy platforms
Find out how BioCardia, Inc.’s Heart3D imaging platform could solve scalability challenges in cardiac cell therapy and reshape regenerative medicine.